Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. - Wikidata - awgldk - TriplyDB

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

http://www.wikidata.org/entity/Q34641267

about

Proteus mirabilis and Urinary Tract Infections.Where does a Staphylococcus aureus vaccine stand?Escherichia coli in Europe: an overview SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains The small RNA RyhB contributes to siderophore production and virulence of uropathogenic Escherichia coli From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.Virulence Genes and Antimicrobial Resistance Pattern in Uropathogenic Escherichia coli Isolated From Hospitalized Patients in Kashan, Iran.Public health evolutionary biology of antimicrobial resistance: priorities for intervention Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli.Network Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical Uropathogens Molecular and Structural Characterization of a Novel Escherichia coli Interleukin Receptor Mimic Protein Development of a Vaccine against Escherichia coli Urinary Tract Infections.Alternative approaches to conventional treatment of acute uncomplicated urinary tract infection in women.Pemphigus vulgaris and infections: a retrospective study on 155 patients.The nature of immune responses to urinary tract infections Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections Draft genome sequences of five recent human uropathogenic Escherichia coli isolates.Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli.Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection Type 1 fimbriae contribute to catheter-associated urinary tract infections caused by Escherichia coli.Proteomic analysis of uropathogenic Escherichia coli.Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis.Antiadhesion agents against Gram-positive pathogens.Effect of Aminophenyl and Aminothiahexyl α-D-Glycosides of the Manno-, Gluco-, and Galacto-Series on Type 1 Fimbriae-Mediated Adhesion of Escherichia coli.Multidrug-resistant Escherichia coli in Asia: epidemiology and management.The emerging threat of multidrug-resistant Gram-negative bacteria in urology.Therapies in early development for the treatment of urinary tract inflammation.E. coli Group 1 Capsular Polysaccharide Exportation Nanomachinary as a Plausible Antivirulence Target in the Perspective of Emerging Antimicrobial Resistance.What is the role of covert infection in detrusor overactivity, and other LUTD? ICI-RS 2013.Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.[Pathogenesis of urinary tract infections : An update].A high-throughput assay for the measurement of uropathogenic Escherichia coli attachment to urinary bladder cells.Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.Purification of intracellular bacterial communities during experimental urinary tract infection reveals an abundant and viable bacterial reservoir.Nanodiamonds facilitate killing of intracellular uropathogenic E. coli in an in vitro model of urinary tract infection pathogenesis.

P2860

Q26779002-0ACDF09D-BA98-49F2-9031-1B3149303565 Q26828726-6A4929CA-257F-4B12-B84B-885376C182A4 Q27015697-344D8D2B-540A-4CBC-B272-541BA62B358C Q27325713-E67BB444-3B5F-4815-A887-C4D83AE0CED9 Q28248484-A087C7D4-C750-4286-9905-C569CE992B40 Q30424697-C908716B-42A0-4E73-A86A-DD090E360167 Q34297628-033A7CCF-294C-4DF1-9F27-3CB177657E03 Q35067216-8158E642-A652-42D4-8C48-1B5146C81F48 Q35187514-EA0396A7-6D0E-4B18-9E4C-EFB0E7F70D1F Q35225481-1020F585-90FD-4EAE-868E-7C2AB359BE8A Q35236703-848D580C-94AF-4107-9DCD-38446D44D4A4 Q35687994-FD5C097F-22D1-40A4-AF1A-0A9876C32A9C Q36124083-AA82864B-C6F0-494A-A493-6BF071E37AA3 Q36677371-6FA10D3E-3FA8-4D91-8F8B-DC5D3DC9BE6C Q36727670-E741C94A-8965-43B5-8469-BA8E686510E6 Q36735378-5CDF6BA0-8A53-44AF-9AEE-ED515B318FC4 Q36754301-0D9465BD-C5FA-4E30-81FF-6F2BF60E37E2 Q36969571-32AC121B-DE9A-4266-AAF4-780D424BC363 Q37050386-CF3C43EA-BDC3-498A-83D9-20CCBACD4230 Q37123720-2F38D362-B1DD-44F1-ADA9-0F3999EDC98E Q37230837-3E110993-675D-4FF5-AED5-C2C20C5A73DC Q37350912-FF8EEDB1-691A-446B-BC6F-1C3BF7CF97A9 Q37379982-86C672C7-9E47-4363-9033-30267D363101 Q37451220-26E2C1CF-1B0E-442A-9D4A-52F116926D57 Q37643400-A2A4B9DF-3E6C-44DC-8E8F-819B28AC07F2 Q38176076-96354D49-9F59-424B-A3AC-B650CC5523F8 Q38202912-23761DFC-C21B-4AD9-874C-A711C991E1A6 Q38269150-A4B08E74-BC8A-4440-B8A6-03171766053E Q38369339-5924C961-9AE9-455C-ABE1-22314BECECFD Q38389612-52CDEA22-2A42-4B01-A31C-BD4579A837DB Q38579512-91A1590A-D81B-498B-B278-91C7696A6714 Q38757968-4CC8214B-5A00-41DF-A07C-4BEA61C684E8 Q39143538-5C2CF969-41BE-48CE-B20C-791BC35B0CEB Q39189283-B4F446F9-8CF9-4CF8-B04F-8ED0D74C261C Q40199741-4BDBD56D-3B84-4DE9-94AB-A7F4B248A501 Q40233051-5DC005B9-D11E-47EC-945F-F2F37BF0A41C Q40641500-DA288D03-352C-471E-A640-4EA96079C817 Q40757720-91F55E89-708D-4F7D-89D3-53D86AD1E26A Q47706415-7A4E1EEA-CDE1-4C41-A46E-F9B55D704EE4 Q48259672-508AFCBD-644D-4727-BDCA-139BDE75D1B3

P2860

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

http://www.wikidata.org/entity/Q34641267

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@ast

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@en

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@nl

type

label

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@ast

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@en

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@nl

prefLabel

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@ast

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@en

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@nl

P1433

Q34641267-A1025D1F-9989-457E-8256-34FDCE1CC32F

P1476

Q34641267-E9448753-F88F-457F-ACBE-E8B5B9C424B8

P2093

Q34641267-DF2DF3F0-CF39-4744-BB3B-22D149E3C305

P2860

Q34641267-011FA723-942F-4F7A-8C79-8D359D8C6D02

Q34641267-0372EF1A-FC16-4192-8B34-CA72AC27DB85

Q34641267-09D99779-AA1C-4A45-9DD6-85A3FE0733DB

Q34641267-0B16BEE1-FBCF-4CF9-8D92-FA34574FFACB

Q34641267-0ED8323D-B4E7-4C31-BF1D-71614DC3EFCA

Q34641267-16BFA159-C195-40AA-AC4E-E1DA65C2BCD1

Q34641267-19928CEC-C4E8-4666-85C1-FE7308BCD8E7

Q34641267-1AF7B4DB-F7EC-414E-8F0C-83329AAB6E59

Q34641267-1D7AACEA-F308-41B5-898D-EBA658FBC699

Q34641267-1DB8D47D-5984-4407-9471-B40CCCE99CFF

P304

Q34641267-442ADB20-69CC-4271-9715-EEAEC6070EFE

P31

Q34641267-AE74F699-8933-4BDF-A1B5-C669391EED49

P356

Q34641267-62D9B76B-E1AC-4FD5-A642-97E821927CF8

P433

Q34641267-6B056B63-D2BA-4098-91FF-49CD2CDAFB51

P478

Q34641267-D75F692F-76A6-480B-8344-77B1CCD03A74

P50

Q34641267-5ED81491-5021-4537-B67E-9B40C190FBF9

P577

Q34641267-29F3DF35-60B8-4E0D-B9A6-3F16B6723E1A

P5875

Q34641267-3E6175E7-40F9-4018-8DF9-EFD143244394

P698

Q34641267-9F141925-FE65-432A-A758-8DDF69505FBA

P921

Q34641267-26A0BAEA-4A3A-48F3-A09E-32009D73DAA5

P932

Q34641267-23AD6663-5E56-42CE-9DCF-CDE94E56F01E

P356

P1433

Expert Review of Vaccines

P1476

Preventing urinary tract infec ...... tive Escherichia coli vaccine.

@en

P2093

Ariel R Brumbaugh

http://www.w3.org/2001/XMLSchema#string

P2860

Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development

Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.

Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract

Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Virulence factors in Escherichia coli urinary tract infection

Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli

Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding

P304

663-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.12.36

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Harry L T Mobley

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230636524

http://www.w3.org/2001/XMLSchema#string

P698

22873125

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli

P932

3498450

http://www.w3.org/2001/XMLSchema#string